[ CAS No. 84964-24-9 ] {[proInfo.proName]}

Name: 84964-24-9|1-(3-Bromophenyl)piperidine|96%
Brand: Ambeed
SKU: A128260
Price: 8.0 USD
Availability: InStock
Rating: 94 (30 reviews)

,{[proInfo.pro_purity]}

Cat. No.: {[proInfo.prAm]}

DV 2D 3D

3d Animation Molecule Structure of 84964-24-9

Structure of 84964-24-9 * Storage: {[proInfo.prStorage]}

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

For Research Only 110K+ Compounds Competitive Price 1-2 Day Shipping

Quality Control of [ 84964-24-9 ]

COA NMR CNMR HPLC LC-MS

Related Doc. of [ 84964-24-9 ]

SDS Specification

Alternatived Products of [ 84964-24-9 ]

Product Details of [ 84964-24-9 ]

CAS No. :	84964-24-9	MDL No. :	MFCD04108532
Formula :	C₁₁H₁₄BrN	Boiling Point :	-
Linear Structure Formula :	-	InChI Key :	PMTXPOLLPCSCBE-UHFFFAOYSA-N
M.W :	240.14	Pubchem ID :	4961269
Synonyms :

Calculated chemistry of [ 84964-24-9 ]

Physicochemical Properties

Num. heavy atoms :	13
Num. arom. heavy atoms :	6
Fraction Csp3 :	0.45
Num. rotatable bonds :	1
Num. H-bond acceptors :	0.0
Num. H-bond donors :	0.0
Molar Refractivity :	63.59
TPSA :	3.24 Å²

Pharmacokinetics

GI absorption :	High
BBB permeant :	Yes
P-gp substrate :	No
CYP1A2 inhibitor :	Yes
CYP2C19 inhibitor :	No
CYP2C9 inhibitor :	No
CYP2D6 inhibitor :	Yes
CYP3A4 inhibitor :	No
Log Kp (skin permeation) :	-5.16 cm/s

Lipophilicity

Log Po/w (iLOGP) :	2.76
Log Po/w (XLOGP3) :	3.67
Log Po/w (WLOGP) :	3.06
Log Po/w (MLOGP) :	3.34
Log Po/w (SILICOS-IT) :	3.25
Consensus Log Po/w :	3.22

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	1.0
Bioavailability Score :	0.55

Water Solubility

Log S (ESOL) :	-3.92
Solubility :	0.0291 mg/ml ; 0.000121 mol/l
Class :	Soluble
Log S (Ali) :	-3.43
Solubility :	0.0897 mg/ml ; 0.000374 mol/l
Class :	Soluble
Log S (SILICOS-IT) :	-3.98
Solubility :	0.0251 mg/ml ; 0.000105 mol/l
Class :	Soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	0.0 alert
Leadlikeness :	2.0
Synthetic accessibility :	1.63

Safety of [ 84964-24-9 ]

Signal Word:	Warning	Class:	N/A
Precautionary Statements:	P261-P305+P351+P338	UN#:	N/A
Hazard Statements:	H302-H315-H319-H335	Packing Group:	N/A
GHS Pictogram:

Application In Synthesis of [ 84964-24-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

Upstream synthesis route of [ 84964-24-9 ]
Downstream synthetic route of [ 84964-24-9 ]

[ 84964-24-9 ] Synthesis Path-Upstream 1~3

1
[ 111-24-0 ]
[ 591-19-5 ]
[ 84964-24-9 ]

Reference： [1] Collection of Czechoslovak Chemical Communications, 1982, vol. 47, # 11, p. 3094 - 3113
[2] Journal of Organic Chemistry, 2009, vol. 74, # 19, p. 7464 - 7469
[3] Journal of Organic Chemistry, 2011, vol. 76, # 1, p. 342 - 345
[4] Patent: WO2015/42397, 2015, A1, . Location in patent: Paragraph 000909

2
[ 110-89-4 ]
[ 108-36-1 ]
[ 84964-24-9 ]

Reference： [1] Synlett, 2005, # 8, p. 1275 - 1278

3
[ 110-89-4 ]
[ 108-36-1 ]
[ 27594-19-0 ]
[ 84964-24-9 ]

Reference： [1] Synlett, 2005, # 8, p. 1275 - 1278

[ 84964-24-9 ] Synthesis Path-Downstream 1~31

1
[ 84964-24-9 ]
[ 84964-25-0 ]

Reference： [1]Collection of Czechoslovak Chemical Communications,1982,vol. 47,p. 3094 - 3113

2
[ 111-24-0 ]
[ 591-19-5 ]
[ 84964-24-9 ]

Yield	Reaction Conditions	Operation in experiment
	With sodium dodecyl-sulfate; sodium hydrogencarbonate; In water; at 100℃; for 1.5h;	[000909] A mixture of Compound 238A (1.72 g, 10 mmol), 1,5-dibromopentane (2.75 g, 12 mmol), sodium dodecyl sulfate (SDS, cat. 40 mg), and sodium bicarbonate (1 g, 12 mmol) in water (20 mL) was heated at 100 C for 1.5 hours. The reaction mixture was treated with water (20 mL) and extracted with ethyl acetate (50 mL x 3). The extraction was washed with water (50 mL), dried over anhydrous sodium sulfate, concentrated, and purified with flash column chromatography on silica gel (ethyl acetate in petroleum ether, from 0% to 1% v/v) to give Compound 238B.

Reference： [1]Collection of Czechoslovak Chemical Communications,1982,vol. 47,p. 3094 - 3113
[2]Journal of Organic Chemistry,2009,vol. 74,p. 7464 - 7469
[3]Journal of Organic Chemistry,2011,vol. 76,p. 342 - 345
[4]Patent: WO2015/42397,2015,A1 .Location in patent: Paragraph 000909

3
[ 110-89-4 ]
[ 108-36-1 ]
[ 27594-19-0 ]
[ 84964-24-9 ]

Reference： [1]Synlett,2005,p. 1275 - 1278

4
[ 110-89-4 ]
[ 108-36-1 ]
[ 84964-24-9 ]

Reference： [1]Synlett,2005,p. 1275 - 1278

5
[ 84964-24-9 ]
[ 84964-29-4 ]

Reference： [1]Collection of Czechoslovak Chemical Communications,1982,vol. 47,p. 3094 - 3113

6
[ 84964-24-9 ]
[ 84964-27-2 ]

Reference： [1]Collection of Czechoslovak Chemical Communications,1982,vol. 47,p. 3094 - 3113

7
[ 84964-24-9 ]
[ 84964-34-1 ]

Reference： [1]Collection of Czechoslovak Chemical Communications,1982,vol. 47,p. 3094 - 3113

8
[ 84964-24-9 ]
[ 84964-31-8 ]

Reference： [1]Collection of Czechoslovak Chemical Communications,1982,vol. 47,p. 3094 - 3113

9
[ 84964-24-9 ]
[ 76-05-1 ]
5-methyl-N₂-(4-(4-methylpiperazin-1-yl)phenyl)-N₄-(3-(piperidin-1-yl)phenyl)-pyrimidine-2,4-diamine [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
8%		[0297] A mixture of l-(3-bromophenyl)piperidine (91 mg, 0.38 mmol), intermediate 32 (99 mg, 0.33 mmol), Pd2(dba)3 (15 mg, 0.02 mmol), Xantphos (24 mg, 0.04 mmol) and cesium carbonate (219 mg, 0.67 mmol) in dioxane (4 mL) was microwaved at 160 C for 15 min. The reaction mixture was cooled to room temperature, concentrated in vacuo, taken up in methanol, and filtered rinsing with DCM and methanol. The filtrate was concentrated and purified by preparative HPLC to afford the TFA salt of the title compound as an off-white solid (14 mg, 8%).[0298] 1H NMR (500 MHz, DMSOd6): delta 1.47-1.53 (m, 2H), 1.56-1.61 (m, 4H), 2.07 (s, 3H), 2.21 (s, 3H), 2.44 (t, J =4.9 Hz, 4H), 3.01 (t, J =4.9 Hz, 4H), 3.08 (t, J=5.4 Hz, 4H), 6.63 (dd, J= 8.2, 2.3 Hz, IH), 6.76 (d, J =9.0 Hz, 2H), 7.12 (t, J= 8.3 Hz, IH), 7.14 (s, IH), 7.27 (d, J =7.6 Hz, IH), 7.50 (d, J=9.0 Hz, 2H), 7.81 (s, IH), 8.00 (s, IH), 8.67 (s, IH). MS (ES+): /rc/z 458 (M+H)+.

Reference： [1]Patent: WO2007/53452,2007,A1 .Location in patent: Page/Page column 154

10
[ 3240-34-4 ]
[ 84964-24-9 ]
C₁₅H₁₈BrNO₄ [ No CAS ]

Reference： [1]Journal of Organic Chemistry,2009,vol. 74,p. 7464 - 7469

11
[ 84964-24-9 ]
[ 90-02-8 ]
[ 1260154-61-7 ]

Reference： [1]Journal of Organic Chemistry,2011,vol. 76,p. 342 - 345

12
[ 84964-24-9 ]
[ 1432450-88-8 ]

Reference： [1]Journal of Medicinal Chemistry,2013,vol. 56,p. 3820 - 3832

13
[ 84964-24-9 ]
[ 73183-34-3 ]
[ 852227-97-5 ]

Reference： [1]Journal of Medicinal Chemistry,2013,vol. 56,p. 3820 - 3832

14
[ 84964-24-9 ]
3,6-bis(piperidin-1-yl)-9-(2-methyl-4-carboxyphenyl)-10,10-dimethyl-10-silaxanthenium chloride [ No CAS ]

Reference： [1]Patent: WO2014/144793,2014,A1

15
[ 50-00-0 ]
[ 84964-24-9 ]
bis(2-bromo-4-(piperidin-1-yl)phenyl)methane [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
	With acetic acid; In water; at 60℃; for 1.91667h;	To a solution of compound <strong>[84964-24-9]1-(3-bromophenyl)-piperidine</strong> (10.0 g, 50.0 mmol)in AcOH (250 mL) was added 12.16 mL of 37% formaldehyde aqueous solution (4.5 g, 150.0mmol), and the mixture was stirred at 60 C for 115 mm. After cooling to room temperature, aportion of acetic acid was removed by vacuum. Then, the reaction mixture was neutralized withsaturated NaHCO3 aq. and NaOH aq., and extracted with CH2C12. The organic layer was washed with brine, dried over Na2504 and evaporated to dryness. The residue was purified by flash chromatography (silica gel) to give bis(2-bromo-4-(piperidin-1-yl)phenyl)methane (5.24 g, 12.7 mmol, 51% yield)

Reference： [1]Patent: WO2014/144793,2014,A1 .Location in patent: Paragraph 00197

16
[ 84964-24-9 ]
[ 95-92-1 ]
C₁₅H₁₉NO₃ [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
		[000910] To a solution of Compound 238B (2.4 g, 10 mmol) in dry THF (50 mL) was added dropwise LDA (2.0 M, 5.0 mL, 12.0 mmol) under nitrogen at -70 C. After stirring for 30 min., diethyl oxalate (2.19 g, 15.0 mmol) was added quickly. The mixture was stirred at - 70 C for about an hour. It was quenched with saturated ammonium chloride (10 mL) solution and extracted with ethyl acetate (50 mL x 3). The combined organic phases were washed with water (5 mL) and brine (5 mL), dried over anhydrous sodium sulfate, filtered, and concentrated to give a residue. The crude product was purified with flash column chromatography on silica gel (ethyl acetate in petroleum ether, from 0% to 10% v/v) to afford Compound 238C.

Reference： [1]Patent: WO2015/42397,2015,A1 .Location in patent: Paragraph 000910

17
[ 84964-24-9 ]
C₁₃H₁₅NO₃ [ No CAS ]

Reference： [1]Patent: WO2015/42397,2015,A1

18
[ 84964-24-9 ]
N-((1R,2R)-1-(3-chloro-4-cyclopropoxyphenyl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)-2-oxo-2-(3-(piperidin-1-yl)phenyl)acetamide [ No CAS ]

Reference： [1]Patent: WO2015/42397,2015,A1

19
[ 84964-24-9 ]
[ 611-73-4 ]
7-(3-bromophenyl)-3-phenyl-5,6,7,7a-tetrahydrofuro[2,3-b]pyridin-2(4H)-one [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
59%	With dmap; iron(III) chloride; di-tert-butyl peroxide; oxygen; In acetonitrile; at 60℃; for 24h;	In the reaction tube by sequentially adding a 1 e (0.5 mmol, 120 mg), 2 a (0.5 mmol, 75 mg), acetonitrile (3 ml), ferric chloride (0.05 mmol, 8.1 mg), di-tert-butyl peroxide (0.5 mmol, 92 mul) and 4 - dimethylamino pyridine (0.05 mmol, 6.1 mg), in oxygen (1 atm) atmosphere at 60 C stirring reaction 24 h. Then, by adding 10 ml saturated salt water quenching reaction, extracted with ethyl acetate (10 ml × 3), combined with the organic phase, dried with anhydrous sodium sulfate. Filtering, turns on lathe does, too separating by silica gel column (petroleum ether/ethyl acetate=10/1) to obtain white solid product 3 e (101 mg, 55%). The compound of the characterization data are as follows:

Reference： [1]Patent: CN107501278,2017,A .Location in patent: Paragraph 0071; 0072; 0073
[2]Advanced Synthesis and Catalysis,2018,vol. 360,p. 261 - 266

20
[ 84964-24-9 ]
1-(3-bromophenyl)pyrrolidine-2-carbaldehyde [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
48%	With oxygen; copper diacetate; potassium iodide; In acetonitrile; at 80℃; under 760.051 Torr; for 12h;Schlenk technique;	To a 10 mL Schlenk tube were added 1f (0.5 mmol, 120 mg)Acetonitrile (5 mL),Copper acetate (0.5 mmol, 90 mg) and potassium iodide (0.5 mmol, 83 mg) were added,Vacuum filled with oxygen (1atm)After that, it was placed in a 80 C. oil bath and the reaction was stirred for 12 h.Then, the reaction was quenched by adding 10 mL of saturated brine and extracted with ethyl acetate (10 mL × 3). The combined organic phases were washed with anhydrousDried over sodium sulfate. Filtration, spin-drying and separation through a silica gel column (petroleum ether / ethyl acetate = 20/1) afforded the product 2f (61 mg,48%).

Reference： [1]Organic Letters,2018,vol. 20,p. 864 - 867
[2]Patent: CN107573270,2018,A .Location in patent: Paragraph 0050-0052

21
[ 3240-34-4 ]
[ 84964-24-9 ]
(1-(3-bromophenyl)pyrrolidin-2-yl)methylene diacetate [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
51%	With oxygen; copper diacetate; In acetonitrile; at 80℃; for 12h;Schlenk technique;	To a 10 mL Schlenk tube, 1d (0.5 mmol, 120 mg), acetonitrile (5 mL), copper acetate (0.5 mmol,90 mg) and (diacetoxyiodo)benzene(0.5 mmol, 161 mg),After evacuating oxygen (1 atm), it was placed in an oil bath at 80 C. and stirred for 12 h.Then, the reaction was quenched by adding 10 mL of saturated saline, and extracted with ethyl acetate (10 mL×3).The organic phases were combined and dried over anhydrous sodium sulfate. Filtration, spin-drying, and column chromatography on silica gel (petroleum ether/ethyl acetate = 10/1) gave the product 2d as an oil (91 mg, 51%).

Reference： [1]Organic Letters,2018,vol. 20,p. 864 - 867
[2]Patent: CN107474001,2017,A .Location in patent: Paragraph 0041-0043

22
[ 84964-24-9 ]
[ 611-73-4 ]
(1-(3-bromophenyl)-1,4,5,6-tetrahydropyridin-3-yl)(phenyl)-methanone [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
64%	With di-tert-butyl peroxide; copper(ll) bromide; In acetonitrile; at 60℃; under 760.051 Torr; for 24h;	In the reaction tube by sequentially adding a 1 e (0.5 mmol, 120 mg), 2 a (0.6 mmol, 90 mg), acetonitrile (3 ml), copper bromide (0.05 mmol, 11 mg) and di-tert-butyl peroxide (1 mmol, 183 mul), in air (1 atm) atmosphere at 60 C stirring reaction 24 h. Then add 10 ml saturated salt water quenching reaction, extracted with ethyl acetate (10 ml × 3), combined with the organic phase, dried with anhydrous sodium sulfate. Filtering, turns on lathe does, too separating by silica gel column (petroleum ether/ethyl acetate=5/1) to get the yellow solid product 3 e (109 mg, 64%).

Reference： [1]Journal of Organic Chemistry,2018,vol. 83,p. 6524 - 6533
[2]Patent: CN108516952,2018,A .Location in patent: Paragraph 0068-0070

23
[ 84964-24-9 ]
1-(3-bromophenyl)-3-iodo-1H-pyrrole [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
60%	With dmap; iodine; oxygen; copper diacetate; In acetonitrile; at 80℃; for 10h;	1i (0.5 mmol, 120 mg), acetonitrile (5 mL), and anhydrous copper acetate (1 mmol) were sequentially added to a 10 mL Shrek tube.181mg), iodine (0.5mmol, 127mg) DMAPand (0.5mmol, 61mg), vacuumed and filled with oxygen (1atm)The reaction was stirred in an 80 C oil bath for 10 h. Then, the reaction was quenched by the addition of 10 mL of brine, and extracted with ethyl acetate (10 mL)3) The organic phases were combined and dried over anhydrous sodium sulfate. Filter, spin dry, and separated on silica gel column (petroleum ether / ethyl acetate = 100/1)Compound 2i (104 mg, 60%) was obtained.
60%	With dmap; iodine; oxygen; copper diacetate; In acetonitrile; at 80℃; under 760.051 Torr; for 10h;Schlenk technique;	Add 1i (0.5 mmol, 120 mg) to a 10 mL Schlenk tube,Acetonitrile (5mL),Anhydrous copper acetate (1mmol, 181mg),Iodine (0.5mmol, 127mg)And DMAP (0.5mmol, 61mg),After evacuating with oxygen (1 atm), it was placed in an 80 C oil bath and stirred for 10 h.Then, the reaction was quenched by adding 10 mL of saturated brine.It was extracted with ethyl acetate (10 mL × 3).Filter, spin dry, and separated on silica gel column (petroleum ether / ethyl acetate = 100/1)Compound 2i (104 mg, 60%) was obtained.
60%	With dmap; iodine; oxygen; copper diacetate; In acetonitrile; at 80℃; for 10h;Schlenk technique;	Add 1i (0.5 mmol, 120 mg) to a 10 mL Schlenktube,Acetonitrile (5mL),Anhydrous copper acetate (1mmol, 181mg),Iodine (0.5mmol, 127mg)And DMAP (0.5mmol, 61mg),After evacuating with oxygen (1 atm), it was placed in an 80 C oil bath and stirred for 10 h.Then, the reaction was quenched by adding 10 mL of saturated brine.It was extracted with ethyl acetate (10 mL × 3).Filter, spin dry, and separated on silica gel column (petroleum ether / ethyl acetate = 100/1)Compound 2i (104 mg, 60%) was obtained.

60%

With dmap; iodine; oxygen; copper diacetate; In acetonitrile; at 80℃; under 760.051 Torr; for 10h;Schlenk technique; Green chemistry;

1i (0.5 mmol, 120 mg), acetonitrile (5 mL), and anhydrous copper acetate (1 mmol, were sequentially added to a 10 mL Shrek tube.181mg), iodine (0. 5mmol, 127mg) and DMAP (0.5mmol, 61mg), vacuumed and filled with oxygen (1atm)The reaction was stirred in an 80 C oil bath for 10 h. Then, the reaction was quenched by the addition of 10 mL of brine, and extracted with ethyl acetate (10 mL)3) The organic phases were combined and dried over anhydrous sodium sulfate. Filter, spin dry, and separated on silica gel column (petroleum ether / ethyl acetate = 100/1)Compound 2i (104 mg, 60%) was obtained. According to the methods of Embodiment 1 and Embodiment 18, 2i can be converted into 3i.

Reference： [1]Organic and biomolecular chemistry,2019,vol. 17,p. 156 - 164
[2]Patent: CN109232356,2019,A .Location in patent: Paragraph 0071; 0072; 0073
[3]Patent: CN109369496,2019,A .Location in patent: Paragraph 0073-0075
[4]Patent: CN109369497,2019,A .Location in patent: Paragraph 0071-0073
[5]Patent: CN109485594,2019,A .Location in patent: Paragraph 0072; 0073; 0074

24
[ 84964-24-9 ]
[ 38348-83-3 ]

Yield	Reaction Conditions	Operation in experiment
56%	With oxone; oxygen; copper diacetate; potassium iodide; In acetonitrile; at 80℃; under 760.051 Torr; for 12h;Schlenk technique;	Add 1i (0.5 mmol, 120 mg) to a 10 mL Shrek tube,Acetonitrile (5mL),Anhydrous copper acetate (1mmol, 181mg),Potassium iodide (1mmol, 166mg)And Oxone (615 mg, 1 mmol),After evacuating with oxygen (1 atm), it was placed in an 80 C oil bath and stirred for 12 h.Then, the reaction was quenched by adding 10 mL of saturated brine.It was extracted with ethyl acetate (10 mL × 3).Filter, spin dry, and separated on silica gel column (petroleum ether / ethyl acetate = 3 / 1)Product 2i (67 mg, 56%) was obtained as a white solid.

Reference： [1]Organic and biomolecular chemistry,2019,vol. 17,p. 156 - 164
[2]Patent: CN109369495,2019,A .Location in patent: Paragraph 0066-0068

25
[ 84964-24-9 ]
N-(3-bromophenyl)-N-(3-cyanopropyl)formamide [ No CAS ]

Reference： [1]Organic Letters,2019,vol. 21,p. 1676 - 1680

26
[ 64-17-5 ]
[ 84964-24-9 ]
ethyl 4-((3-bromophenyl)(nitroso)amino)butanoate [ No CAS ]

Reference： [1]Organic Letters,2019,vol. 21,p. 1676 - 1680

27
[ 84964-24-9 ]
1-(3-bromophenyl)-3-hydroxypiperidin-2-one [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
43%	With 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; bis(1-methyl-1-phenylethyl)peroxide; copper(ll) bromide; In acetonitrile; at 100℃; for 24h;Sealed tube; Green chemistry;	General procedure: To a reaction tube containing a solution of 1-phenylpiperidine (1a, 81 mg, 0.5 mmol) in CH3CN (2 mL) were added CuBr2 (11 mg, 0.05 mmol), DCP (135 mg, 0.5 mmol) and TEMPO (78 mg, 0.5 mmol). Then the tube was sealed, and the mixture was stirred at 100 C under air for 24 h. Upon completion, it was quenched with saturated brine, and extracted with EtOAc (10 mL x 3). The combined organic phases were dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel with petroleum ether/ethyl acetate (5:1) as the eluent to give 2a. Other products 2b-2p were obtained in a similar manner.

Reference： [1]Tetrahedron Letters,2019,vol. 60

28
[ 84964-24-9 ]
N-(3-bromophenyl)-N-(3-cyanopropyl)formamide [ No CAS ]
1-(3-bromophenyl)-5-nitro-1,2,3,4-tetrahydropyridine [ No CAS ]

Reference： [1]Chemical Communications,2019,vol. 55,p. 12372 - 12375

29
2,2,6,6-tetramethylpiperidine-1-oxoammonium tetrafluoroborate [ No CAS ]
[ 84964-24-9 ]
N-(3-bromophenyl)-N-(5-oxo-4-((2,2,6,6-tetramethylpiperidin-1-yl)oxy)pentyl)nitrous amide [ No CAS ]

Reference： [1]Chemical Communications,2019,vol. 55,p. 12372 - 12375

30
[ 84964-24-9 ]
[ 98-86-2 ]
1-(1-(3-bromophenyl)-1,4,5,6-tetrahydropyridin-3-yl)-2-phenylethane-1,2-dione [ No CAS ]

Reference： [1]Journal of Organic Chemistry,2020

31
[ 84964-24-9 ]
[ 67-64-1 ]
1-(1-(3-bromophenyl)-1,4,5,6-tetrahydropyridin-3-yl)propane-1,2-dione [ No CAS ]

Reference： [1]Journal of Organic Chemistry,2020

Same Skeleton Products

Related Products

Historical Records

Related Functional Groups of
[ 84964-24-9 ]

Aryls

[ 22090-26-2 ]

N-(4-Bromophenyl)pyrrolidine

Similarity: 0.93

[ 219928-13-9 ]

1-(3-Bromophenyl)pyrrolidine

Similarity: 0.93

[ 107302-22-7 ]

1-(3-Bromophenyl)-1H-pyrrole

Similarity: 0.84

[ 5044-39-3 ]

1-(4-Bromophenyl)-1H-pyrrole

Similarity: 0.84

[ 16518-62-0 ]

3-Bromo-N,N-dimethylaniline

Similarity: 0.84

Bromides

[ 22090-26-2 ]

N-(4-Bromophenyl)pyrrolidine

Similarity: 0.93

[ 219928-13-9 ]

1-(3-Bromophenyl)pyrrolidine

Similarity: 0.93

[ 107302-22-7 ]

1-(3-Bromophenyl)-1H-pyrrole

Similarity: 0.84

[ 5044-39-3 ]

1-(4-Bromophenyl)-1H-pyrrole

Similarity: 0.84

[ 16518-62-0 ]

3-Bromo-N,N-dimethylaniline

Similarity: 0.84

Related Parent Nucleus of
[ 84964-24-9 ]

Piperidines

[ 2359-60-6 ]

4-Piperidinoaniline

Similarity: 0.75

[ 63921-23-3 ]

1-Phenylpiperidin-4-amine

Similarity: 0.70

[ 142752-12-3 ]

1-(4-Aminophenyl)piperidin-4-ol

Similarity: 0.69

[ 436096-88-7 ]

2,4-Di(piperidin-1-yl)aniline

Similarity: 0.69

[ 1082662-38-1 ]

1-Phenylpiperidin-4-amine dihydrochloride

Similarity: 0.69

Ghs Precautionary Statements

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Purity	Size	Price	VIP Price	USA Stock *0-1 Day	Global Stock *5-7 Days	Quantity
{[ item.p_purity ]}	{[ item.pr_size ]}	{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]}	{[ getRatePrice(item.pr_usd, 1,1) ]}	Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]}	{[ item.pr_usastock ]}	Inquiry -	{[ item.pr_chinastock ]}	Inquiry -

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed
H304	May be fatal if swallowed and enters airways
H305	May be harmful if swallowed and enters airways
H310	Fatal in contact with skin
H311	Toxic in contact with skin
H312	Harmful in contact with skin
H313	May be harmful in contact with skin
H314	Causes severe skin burns and eye damage
H315	Causes skin irritation
H316	Causes mild skin irritation
H317	May cause an allergic skin reaction
H318	Causes serious eye damage
H319	Causes serious eye irritation
H320	Causes eye irritation
H330	Fatal if inhaled
H331	Toxic if inhaled
H332	Harmful if inhaled
H333	May be harmful if inhaled
H334	May cause allergy or asthma symptoms or breathing difficulties if inhaled
H335	May cause respiratory irritation
H336	May cause drowsiness or dizziness
H340	May cause genetic defects
H341	Suspected of causing genetic defects
H350	May cause cancer
H351	Suspected of causing cancer
H360	May damage fertility or the unborn child
H361	Suspected of damaging fertility or the unborn child
H361d	Suspected of damaging the unborn child
H362	May cause harm to breast-fed children
H370	Causes damage to organs
H371	May cause damage to organs
H372	Causes damage to organs through prolonged or repeated exposure
H373	May cause damage to organs through prolonged or repeated exposure
Environmental hazards
Code	Phrase
H400	Very toxic to aquatic life
H401	Toxic to aquatic life
H402	Harmful to aquatic life
H410	Very toxic to aquatic life with long-lasting effects
H411	Toxic to aquatic life with long-lasting effects
H412	Harmful to aquatic life with long-lasting effects
H413	May cause long-lasting harmful effects to aquatic life
H420	Harms public health and the environment by destroying ozone in the upper atmosphere

[ CAS No. 84964-24-9 ] {[proInfo.proName]}

Quality Control of [ 84964-24-9 ]

Related Doc. of [ 84964-24-9 ]

Product Details of [ 84964-24-9 ]

Calculated chemistry of [ 84964-24-9 ]

Physicochemical Properties

Pharmacokinetics

Lipophilicity

Druglikeness

Water Solubility

Medicinal Chemistry

Safety of [ 84964-24-9 ]

Application In Synthesis of [ 84964-24-9 ]

[ 84964-24-9 ] Synthesis Path-Upstream 1~3

[ 84964-24-9 ] Synthesis Path-Downstream 1~31

Related Functional Groups of [ 84964-24-9 ]

Aryls

Bromides

Related Parent Nucleus of [ 84964-24-9 ]

Piperidines

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Related Functional Groups of
[ 84964-24-9 ]

Related Parent Nucleus of
[ 84964-24-9 ]